402 related articles for article (PubMed ID: 33068560)
1. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.
Finney LJ; Glanville N; Farne H; Aniscenko J; Fenwick P; Kemp SV; Trujillo-Torralbo MB; Loo SL; Calderazzo MA; Wedzicha JA; Mallia P; Bartlett NW; Johnston SL; Singanayagam A
J Allergy Clin Immunol; 2021 Feb; 147(2):510-519.e5. PubMed ID: 33068560
[TBL] [Abstract][Full Text] [Related]
2. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
[TBL] [Abstract][Full Text] [Related]
3. Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
Fließer E; Birnhuber A; Marsh LM; Gschwandtner E; Klepetko W; Olschewski H; Kwapiszewska G
J Pathol Clin Res; 2021 Sep; 7(5):446-458. PubMed ID: 33978304
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.
O'Beirne SL; Salit J; Kaner RJ; Crystal RG; Strulovici-Barel Y
Respir Res; 2021 Jul; 22(1):200. PubMed ID: 34233672
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease.
Tomchaney M; Contoli M; Mayo J; Baraldo S; Li S; Cabel CR; Bull DA; Lick S; Malo J; Knoper S; Kim SS; Tram J; Rojas-Quintero J; Kraft M; Ledford JG; Tesfaigzi Y; Martinez FD; Thorne CA; Kheradmand F; Campos SK; Papi A; Polverino F
BMC Pulm Med; 2021 Aug; 21(1):275. PubMed ID: 34425811
[TBL] [Abstract][Full Text] [Related]
6. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.
Schultze A; Walker AJ; MacKenna B; Morton CE; Bhaskaran K; Brown JP; Rentsch CT; Williamson E; Drysdale H; Croker R; Bacon S; Hulme W; Bates C; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; Tomlinson L; Mathur R; Wing K; Wong AYS; Forbes H; Parry J; Hester F; Harper S; Evans SJW; Quint J; Smeeth L; Douglas IJ; Goldacre B;
Lancet Respir Med; 2020 Nov; 8(11):1106-1120. PubMed ID: 32979987
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of COVID-19 related gene expression in the COPD lung.
Watson A; Öberg L; Angermann B; Spalluto CM; Hühn M; Burke H; Cellura D; Freeman A; Muthas D; Etal D; Belfield G; Karlsson F; Nordström K; Ostridge K; Staples KJ; Wilkinson T;
Respir Res; 2021 May; 22(1):164. PubMed ID: 34051791
[TBL] [Abstract][Full Text] [Related]
8. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
Ziegler CGK; Allon SJ; Nyquist SK; Mbano IM; Miao VN; Tzouanas CN; Cao Y; Yousif AS; Bals J; Hauser BM; Feldman J; Muus C; Wadsworth MH; Kazer SW; Hughes TK; Doran B; Gatter GJ; Vukovic M; Taliaferro F; Mead BE; Guo Z; Wang JP; Gras D; Plaisant M; Ansari M; Angelidis I; Adler H; Sucre JMS; Taylor CJ; Lin B; Waghray A; Mitsialis V; Dwyer DF; Buchheit KM; Boyce JA; Barrett NA; Laidlaw TM; Carroll SL; Colonna L; Tkachev V; Peterson CW; Yu A; Zheng HB; Gideon HP; Winchell CG; Lin PL; Bingle CD; Snapper SB; Kropski JA; Theis FJ; Schiller HB; Zaragosi LE; Barbry P; Leslie A; Kiem HP; Flynn JL; Fortune SM; Berger B; Finberg RW; Kean LS; Garber M; Schmidt AG; Lingwood D; Shalek AK; Ordovas-Montanes J; ;
Cell; 2020 May; 181(5):1016-1035.e19. PubMed ID: 32413319
[TBL] [Abstract][Full Text] [Related]
10. Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients.
Saheb Sharif-Askari F; Goel S; Saheb Sharif-Askari N; Hafezi S; Al Heialy S; Hachim MY; Hachim IY; Mahboub B; Salameh L; Abdelrazig M; Elzain EI; Al-Muhsen S; Al-Hajjaj MS; Ratemi E; Hamid Q; Halwani R
Front Immunol; 2021; 12():796094. PubMed ID: 35111161
[TBL] [Abstract][Full Text] [Related]
11. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease.
Peng Y; Wang ZN; Chen SY; Xu AR; Fang ZF; Sun J; Zhou ZQ; Hou XT; Cen LJ; Ma JJ; Zhao JC; Guan WJ; Wang DY; Zhong NS
Am J Physiol Lung Cell Mol Physiol; 2022 May; 322(5):L712-L721. PubMed ID: 35318858
[TBL] [Abstract][Full Text] [Related]
13. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.
Eapen MS; Lu W; Hackett TL; Singhera GK; Thompson IE; McAlinden KD; Hardikar A; Weber HC; Haug G; Wark PAB; Chia C; Sohal SS
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L158-L163. PubMed ID: 33174446
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
[TBL] [Abstract][Full Text] [Related]
16. COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.
Peters MC; Sajuthi S; Deford P; Christenson S; Rios CL; Montgomery MT; Woodruff PG; Mauger DT; Erzurum SC; Johansson MW; Denlinger LC; Jarjour NN; Castro M; Hastie AT; Moore W; Ortega VE; Bleecker ER; Wenzel SE; Israel E; Levy BD; Seibold MA; Fahy JV
Am J Respir Crit Care Med; 2020 Jul; 202(1):83-90. PubMed ID: 32348692
[No Abstract] [Full Text] [Related]
17. Epithelial cell-specific loss of function of
Do-Umehara HC; Chen C; Zhang Q; Misharin AV; Abdala-Valencia H; Casalino-Matsuda SM; Reyfman PA; Anekalla KR; Gonzalez-Gonzalez FJ; Sala MA; Peng C; Wu P; Wong CCL; Kalhan R; Bharat A; Perlman H; Ridge KM; Sznajder JI; Sporn PHS; Chandel NS; Yu J; Fu X; Petrache I; Tuder R; Budinger GRS; Liu J
Sci Adv; 2020 Aug; 6(33):eabb7238. PubMed ID: 32851183
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.
Singanayagam A; Glanville N; Girkin JL; Ching YM; Marcellini A; Porter JD; Toussaint M; Walton RP; Finney LJ; Aniscenko J; Zhu J; Trujillo-Torralbo MB; Calderazzo MA; Grainge C; Loo SL; Veerati PC; Pathinayake PS; Nichol KS; Reid AT; James PL; Solari R; Wark PAB; Knight DA; Moffatt MF; Cookson WO; Edwards MR; Mallia P; Bartlett NW; Johnston SL
Nat Commun; 2018 Jun; 9(1):2229. PubMed ID: 29884817
[TBL] [Abstract][Full Text] [Related]
19. ACE2 expression in allergic airway disease may decrease the risk and severity of COVID-19.
Chhapola Shukla S
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2637-2640. PubMed ID: 33025046
[TBL] [Abstract][Full Text] [Related]
20. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
